UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Historical Holders from Q3 2021 to Q2 2025

Symbol
UNCY on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
18.6M
All holders as of 30 Jun 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-29
Average Value change %
0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 9.99% $38.4M 61M Vivo Opportunity Fund Holdings, L.P. 31 Mar 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% 0% $8.37M $1.11M 13.3M +15.3% RA Capital Management, L.P. 31 Mar 2025
GREAT POINT PARTNERS LLC 9.99% $7.23M 11.5M Great Point Partners, LLC 31 Dec 2024
Walleye Capital LLC 4.82% $3.15M 5M Walleye Capital LLC 31 Dec 2024
Nantahala Capital Partners Limited Partnership 2.76% -62.5% $1.9M -$3.07M 3.01M -61.9% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 19 Dec 2024
Nantahala Capital Management, LLC 9.99% 0% $1.39M $466K 1.86M +50.3% Nantahala Capital Management, LLC 30 Sep 2025

Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$34.5M 0
2025 Q1 59.9M $34.5M -$1.35M $0.57 29
2024 Q4 61.7M $49M +$12.1M $0.79 31
2024 Q3 46.8M $19.1M +$10.6M $0.41 28
2024 Q2 19M $9.52M -$954K $0.50 23
2024 Q1 14.4M $19.9M +$6.69M $1.38 21
2023 Q4 13M $11.3M -$1.01M $0.87 16
2023 Q3 14.2M $12.2M +$11.2M $0.86 16
2023 Q2 1.07M $1.38M -$1.38M $1.28 15
2023 Q1 1.69M $3.54M +$1.99M $2.10 13
2022 Q4 795K $428K -$100K $0.54 9
2022 Q3 968K $571K -$128K $0.59 11
2022 Q2 1.19M $992K +$8.18K $0.83 14
2022 Q1 1.15M $1.48M +$40.9K $1.28 11
2021 Q4 1.12M $2.3M -$90.2K $2.06 9
2021 Q3 1.07M $3.02M +$3.02M $2.83 9